Nixxy, Inc. (NIXX): Nasdaq/NYSE listing notice — Nixxy receives Nasdaq notice for bid price below $1.00; 180-day cure period

Nixxy, Inc.

Received Nasdaq notice on Feb 20, 2026, for minimum bid price non-compliance.
Consolidated closing bid price below $1.00 for 30 consecutive business days.
Afforded 180-day grace period to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant, may be eligible for second 180-day period; otherwise could face delisting.
Company intends to monitor and consider options, including reverse stock split if needed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nixxy, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 20, 2026, Nixxy, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s consolidated closing bid price has been below $1.00 per share for 30 consecutive business days and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which is the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Nixxy, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-001318

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.